Portfolio

We are enabling companies to turn their boldest ambitions into world-changing breakthroughs in healthcare and technology.

Portfolio

Spotlights Portfolio List

Portfolio List

Regulates stablecoin for efficient global transactions and yield generation.
Explores Glia's role in brain disease, acquired by Neumora.
Acquired by Neumora
Develops innovative embolotherapy using inorganic polymer microspheres for hypervascular tumors.
Democratizes flow cytometry for medical research.
Acquired by Becton Dickinson
Develops innovative therapies for unmet needs in dermatology and immunodermatology.
NASDAQ:ACRS
Develops protein conjugate therapies, combining biologics and small molecule payloads to treat cancer.
Uses genome-wide methylation analysis for earlier, precise cancer and morbidity detection.
Developing a protein nanoparticle (PNP) delivery platform.
Develops transformative gene therapies for devastating diseases using rationally designed AAV vectors.
Supports the Liquid Collective protocol, fostering growth in proof-of-stake blockchains.
Developed minimally invasive medical devices to restore quality of life from Overactive Bladder Syndrome.
Acquired by Hologic
Develops novel therapies by inhibiting the complement system at the C3 level.
NASDAQ: APLS
Develops alpha radioligand therapies (ARTs) for targeted cancer treatment with resilient supply chain.
Developing neurodegenerative disease treatments using proprietary RNA interference platform.
Develops improved therapies for idiopathic pulmonary fibrosis (IPF) and other respiratory diseases.
Develops CAR-T cell therapies using switchable and scalable platforms for cancers.
Pioneering gene therapy company focused on transformative medicines for neurodegenerative disorders.
Developing innovative neuromodulation technology to treat large disease populations.
Developing innovative neuromodulation technology to treat large disease populations.
Develops innovative orthopedic solutions to restore patient mobility and enhance surgical outcomes.
Pioneering CRISPR base editing for precision genetic medicines to treat disease.
NASDAQ: BEAM
Modern software and AI tools for bioscientists.
Develops biologics combining targeted therapy with tumor modulators to enhance immune activity.
NASDAQ:BCAX
Focuses on developing therapies for diseases of the eye.
Acquired by Shire
Developed a CE-Marked product for improving dialysis access surgery.
Offering data analysis and proof-of-stake rewards.
Acquired by Coinbase
Precision therapy company striving to improve human health.
Acquired by Sanofi / NASDAQ: BPMC
Develops therapies for epilepsy and other neurological disorders with neural implant technology.
Developed lixivaptan for hyponatremia treatment.
Acquired by Cornerstone Therapeutics
Pioneering CRISPR genome editing for new medical therapies.
NASDAQ: CRBU
Provides secure tools for Bitcoin self-custody, empowering individuals to manage their wealth.
Provides real-time monitoring, simulations, and dynamic risk oracles to enhance DeFi protocol security.
Immune-activating cancer therapy company acquired by Regeneron in 2022, developed vidutolimod.
Acquired by Regeneron / NASDAQ: CMPI
Develops antibody-coupled T-cell receptor platform to target and kill tumor cells.
NASDAQ:COGT
Develops and commercializes high-quality biosimilar therapeutics worldwide using advanced analytics.
Leading crypto financial intelligence provider offering data and risk solutions since 2017.
Developing the first therapy targeting a root cause of preterm preeclampsia to reduce risks for mothers and babies, including premature birth.
Develops antibodies targeting tumor-immune synapse for comprehensive cancer treatment.
NASDAQ: CMPX
Redefining PCR with single-molecule precision and category-defining sensitivity.
Seed-stage venture firm and accelerator for therapeutics startups, providing expertise and capital.
Developing therapies for neurodegenerative diseases through rigorous research.
NASDAQ: DNLI
Crypto data provider acquired by NYDIG in 2021 for research enhancement.
Acquired by NYDIG
AAV gene therapy developer for rare diseases.
Acquired by Ultragenyx Pharmaceuticals
Real-world asset tokenization platform bringing US stocks to international markets via blockchain.
Offers a leading authentication solution using digital thread technology for object tracking and verification.
Offering tax-optimized Bitcoin and Ethereum SMAs.
Providing insights and compliance solutions for crypto transactions.
Developing innovative therapies for neurological and psychiatric disorders.
Developing curative medicines through precision in vivo cellular engineering.
Providing liquidity and prime brokerage services to institutional investors.
Developing pulsed field ablation technology for cardiac arrhythmia treatment.
Acquired by Boston Scientific
Offering staking, node management, and Web3 development services.
Providing data intelligence and insights for crypto projects.
Developing small molecule therapeutics for protein misfolding and aggregation diseases.
Acquired by Pfizer
Improving diagnostic testing and accelerate drug discovery in diverse underserved populations.
Provides scalable decentralized infrastructure for Web3 applications, enabling seamless interaction with open-source protocols.
Providing proof-of-assets and wealth management solutions through bitcoin-focused financial services.
Developing Midazolam Nasal Spray (USL261) for acute repetitive seizures.
Acquired by UCB
Dedicated to developing novel treatments for fibrotic diseases.
Offers custom training programs for financial services and corporations through e-learning solutions.
Developing novel protein-based therapeutics for companion animals.
Acquired by Dechra
Developing and commercializing innovative medicines focused on gastrointestinal diseases.
NASDAQ: IRWD
Eliminating infusion-related patient harm.
Acquired by Fresenius Kabi
Targets epigenetic pathways to develop innovative cancer therapies.
Offers liquid staking on Monad, combining zero-knowledge cryptography with decentralized validator networks.
Developing nasal spray products to prevent respiratory viruses.
Developing innovative vaccines for the prevention of gastrointestinal diseases.
Acquired by Takeda
Developing antibody-drug conjugates for cancer treatment.
NASDAQ: MRSN
Developing next-generation medicines for obesity and metabolic diseases.
NASDAQ: MTSR
Develops targeted therapies for rare genetic diseases and mitochondrial disorders.
Acquired by Zogenix
Creating player-owned economies in video games blockchain-based game technology.
Offers streaming and downloading of millions of songs.
Revolutionizing in vivo targeted genetic medicines with best-in-class cargo and precision delivery.
Providing whole genome sequencing and analysis services through personal genomics.
Acquired by ProPhase Labs
Developing precision medicines for brain diseases.
NASDAQ: NMRA
Creates and promotes differentiated products in the pediatric market.
Acquired by Pfizer
Develops targeted therapies for fibrotic diseases and other dermatological conditions.
Developing novel therapeutics for neurogenic cough and inflammation.
Accelerating the advancement of globally competitive oncology assets for patients.
Enabls fast, secure, and low-cost cryptocurrency transactions through their bitcoin payment infrastructure.
Offers flexible, scalable, and customizable mobile network solutions through cloud-based telecom.
Providing tools and insights for secure digital asset management through cryptocurrency investment .
Engineering advanced therapies for genetic and oncological diseases through genome editing.
NASDAQ: DTIL
Pioneering gene-editing solutions using precision genome engineering technologies.
NASDAQ: PRME
Developing therapies for neuropsychiatric and neurodevelopmental disorders.
Developing therapies targeting protein misfolding diseases.
Merged with Yumanity Therapeutics in 2020
Offers secure, user-friendly cryptocurrency staking solutions.
Empowering financial institutions with insights for wealth management solutions through data aggregation.
NASDAQ: RLYB
Developing precision diagnostic solutions for cell analysis and research.
Providing secure, transparent solutions for deposit management.
Advancing AAV-based treatments for rare genetic diseases through gene therapy.
NASDAQ: RGNX
Developing gene therapies for retinal diseases causing blindness.
Developing RNA-based therapeutics for immune modulation and viral defense.
Discovering and developing novel first-in-class small molecule drugs with the potential to address multiple psychiatric indications.
Developing cell and gene therapies for complex diseases.
NASDAQ: SANA
Developing cell therapies for treating type 1 diabetes.
Acquired by Vertex
Pioneering novel immunotherapies for cancer treatment.
Developing advanced DNA sequencing solutions though genomics technology.
NASDAQ: OMIC
Ensures digital asset market integrity through risk monitoring tools.
Enhancing data security and reliability for Web3 applications.
Developing oral therapies for chronic metabolic and cardiovascular diseases.
NASDAQ: GPCR
Developing next-generation antibody therapies focused on the tumor microenvironment.
NASDAQ:SURF
Developing innovative treatments for women’s health conditions.
Transforming global drug discovery with advanced AI and physics-based technologies.
Develops small molecule therapeutics designed to effectively treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
NASDAQ: TPST
Improving the lives of patients and caregivers impacted by neurological, cardiometabolic, and ophthalmic diseases.
Developing antibiotics for multi-drug-resistant infections.
NASDAQ: TTPH
Connecting nonprofits with crypto donors worldwide.
Acquired by Shift4
Enables compliant digital asset issuance and management.
Developing treatments for pediatric infectious diseases.
Acquired by Sanofi
Developing inhaled therapies for respiratory and lung infections.
Acquired by Insmed Inc.
Developing cancer therapies that activate T-cell responses through immuno-oncology.
NASDAQ: TSBX
Developing innovative treatments for rare and ultra-rare diseases.
NASDAQ: RARE
Developing treatments for cardiovascular diseases though gene-editing.
NASDAQ: VERV
Developing treatments for dermatological conditions like rosacea.
Acquired by Allergan
Developing MRI-guided radiation therapy systems for cancer treatment.
NASDAQ: VRAY
Developing treatments for immuno-inflammatory conditions.
NASDAQ: VYNE
Developing AI-driven therapies for complex diseases.
Engineering tumor-activated therapies for targeted cancer treatment.
NASDAQ: XLO
Developing minimally invasive treatments for benign prostatic hyperplasia.
The companies identified do not represent all the companies purchased, sold, or recommended for portfolios advised by F-Prime.